OBGYN || FDA & CDC

FDA approves palbociclib with letrozole for advanced postmenopausal breast cancer

Posted on: 03/02/2015 - 23:53

Palbociclib, a cyclin-dependent kinase 4/6 inhibitor, has been approved by the Food and Drug Administration for treating postmenopausal women with est... More »

Field of Interest: Pulmonology

Type: News Item

FDA approves palbociclib with letrozole for advanced postmenopausal breast cancer

Posted on: 03/02/2015 - 23:53

Palbociclib, a cyclin-dependent kinase 4/6 inhibitor, has been approved by the Food and Drug Administration for treating postmenopausal women with est... More »

Field of Interest: Oncology

Type: News Item

FDA issues new pregnancy/lactation drug label standards

Posted on: 03/12/2014 - 21:23

The U.S. Food and Drug Administration has issued a final rule requiring content and format changes to pregnancy and lactation labeling information for prescription drugs and biologic products. The...

Field of Interest: Pulmonology

Type: News Item

Abortion rates reach historic low in 2011

Posted on: 02/12/2014 - 17:04

The total number of abortions, the rate of abortions per 1,000 women, and the ratio of abortions to live births all reached historic lows in 2011, according to a study published in Morbidity and...

Field of Interest: Pulmonology

Type: News Item

Pap testing much less likely in women without regular provider

Posted on: 12/11/2014 - 20:14

Adult women with no regular health care provider or no health insurance were much less likely to have been screened for cervical cancer in the past 5 years, a study from the Centers for Disease...

Field of Interest: Pulmonology

Type: News Item

Pap testing much less likely in women without regular provider

Posted on: 12/11/2014 - 20:14

Adult women with no regular health care provider or no health insurance were much less likely to have been screened for cervical cancer in the past 5 years, a study from the Centers for Disease...

Field of Interest: Oncology

Type: News Item

Pregnancy exposure registries confirmed useful in assessing product safety

Posted on: 12/08/2014 - 19:40

BELLEVUE, WASH. – Registries that collect data on pregnant women’s exposures to medical products and outcomes are contributing to product safety in this population, as intended, suggests an...

Field of Interest: Pulmonology

Type: News Item

FDA advises against Enhancement intranasal splint as dermal filler

Posted on: 06/08/2014 - 18:00

The Food and Drug Administration has issued a warning about adverse events associated with use of the Expression intranasal splint as a dermal filler

Field of Interest: Dermatology

Type: News Item

High gonorrhea reinfection rate underscores need for rescreening

Posted on: 27/06/2014 - 18:10

ATLANTA – Gonorrhea reinfection rates are high among women in Florida, with more than 1 in 4 becoming reinfected after treatment, according to a review of surveillance data. Of 9,923 female Florida...

Field of Interest: Pulmonology

Type: News Item

FDA approves palbociclib with letrozole for advanced postmenopausal breast cancer

FDA approves palbociclib with letrozole for advanced postmenopausal breast cancer

FDA issues new pregnancy/lactation drug label standards

Abortion rates reach historic low in 2011

Pap testing much less likely in women without regular provider

Pap testing much less likely in women without regular provider

Pregnancy exposure registries confirmed useful in assessing product safety

FDA advises against Enhancement intranasal splint as dermal filler

High gonorrhea reinfection rate underscores need for rescreening

Newsletters

Latest Newsletters

You are here

OBGYN || FDA & CDC

Newsletters

Latest Newsletters